AUNA AUNA S.A. IFRS
Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1799207 · Reporting currency PEN
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY13.2%
TTM net income YoY143.4%
TTM EPS YoY128.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin39.3%
Operating margin17.9%
Net margin2.5%
FCF margin13.2%
EBITDA margin22.9%
Returns
ROE7.5%
ROA1.5%
ROIC (approx.)10.7%
Asset turnover0.59x
Leverage & solvency
Liabilities / assets77.1%
Debt / equity2.45x
Current ratio0.88x
Interest coverage1.38x
Cash quality & payout
Operating cash flow / net income6.06x
Accruals ratio-7.6%
Payout ratio1.0%
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: PEN | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 4.39B | 3.88B |
| Cost of revenue | 2.66B | 2.44B |
| Gross profit | 1.73B | 1.44B |
| Operating income | 783.76M | 560.34M |
| Interest expense | 567.07M | 766.66M |
| Pretax income | 183.78M | -124.17M |
| Income tax | 59.82M | 90.17M |
| Net income | 110.27M | -253.92M |
| EBITDA | 1.00B | 796.09M |
| EPS (basic) | 1.64 | -5.78 |
| EPS (diluted) | 1.63 | -5.78 |
| Weighted avg. shares (diluted) | 67.50M | 43.92M |
| Balance sheet | ||
| Cash & equivalents | 235.75M | 241.13M |
| Short-term investments | 100.23M | 93.13M |
| Receivables | 961.89M | 860.92M |
| Inventory | 143.76M | 130.52M |
| Current assets | 1.70B | 1.55B |
| PP&E, netmay include right-of-use assets (IFRS) | 2.28B | 2.57B |
| Goodwill | 1.75B | 2.07B |
| Total assets | 7.08B | 7.69B |
| Current liabilities | 1.95B | 1.69B |
| Short-term debt | 654.23M | 385.30M |
| Long-term debt | 2.97B | 3.38B |
| Total debt | 3.62B | 3.76B |
| Total liabilities | 5.46B | 5.91B |
| Shareholders' equity | 1.48B | 1.47B |
| Net debt | 3.38B | 3.52B |
| Shares outstanding | 73.97M | 43.92M |
| Cash flow statement | ||
| Operating cash flow | 668.50M | 582.41M |
| Capital expenditure | 90.86M | 116.25M |
| Free cash flow | 577.64M | 466.17M |
| Investing cash flow | -236.82M | -173.15M |
| Financing cash flow | -418.12M | -370.00M |
| Depreciation & amortization | 219.15M | 235.75M |
| Stock-based compensation | 9.14M | 3.67M |
| Dividends paid | 1.15M | 6.84M |
Free plan shows the latest 2 periods; Pro shows all 3 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Amounts are in the company's reporting currency, PEN, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.